Hitting Them Where They Live: Targeting the Glioblastoma Perivascular Stem Cell Niche

Current Pathobiology Reports

Volumn 1, Issue 2, 2013, Pages 101-110

  Brooks, Michael D ^a   Sengupta, Rajarshi ^a   Snyder, Steven C ^a   Rubin, Joshua B ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anti angiogenic therapy; Cadherins; Glioblastoma; Integrins; Perivascular niche; Stem cell

Indexed keywords

EID: 84900014678     PISSN: None     EISSN: 2167485X     Source Type: Journal    
DOI: 10.1007/s40139-013-0012-0     Document Type: Review

References (108)

1. Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285:1182–1186
2. Zhu TS, Costello MA, Talsma CE et al (2011) Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells. Cancer Res 71:6061–6072
3. Calabrese C, Poppleton H, Kocak M et al (2007) A perivascular niche for brain tumor stem cells. Cancer Cell 11:69–82
4. Charles N, Ozawa T, Squatrito M et al (2010) Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. Cell Stem Cell 6:141–152
5. Galan-Moya EM, Le Guelte A, Lima Fernandes E et al (2011) Secreted factors from brain endothelial cells maintain glioblastoma stem-like cell expansion through the mTOR pathway. EMBO Rep 12:470–476
6. Folkins C, Man S, Xu P, Shaked Y, Hicklin DJ, Kerbel RS (2007) Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors. Cancer Res 67:3560–3564
7. Rao S, Sengupta R, Choe EJ et al (2012) CXCL12 mediates trophic interactions between endothelial and tumor cells in glioblastoma. PLoS ONE 7:e33005
8. Wu Y, Peng H, Cui M, Whitney NP, Huang Y, Zheng JC (2009) CXCL12 increases human neural progenitor cell proliferation through Akt-1/FOXO3a signaling pathway. J Neurochem 109:1157–1167
9. Becher OJ, Hambardzumyan D, Fomchenko EI et al (2008) Gli activity correlates with tumor grade in platelet-derived growth factor-induced gliomas. Cancer Res 68:2241–2249
10. Clement V, Sanchez P, de Tribolet N, Radovanovic I, Ruiz i Altaba A (2007) HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol 17:165–172
11. Kusumbe AP, Bapat SA (2009) Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy. Cancer Res 69:9245–9253
12. Quesnel B (2008) Tumor dormancy and immunoescape. APMIS 116:685–694
13. Hardee ME, Marciscano AE, Medina-Ramirez CM et al (2012) Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-beta. Cancer Res 72:4119–4129
14. Liu G, Yuan X, Zeng Z et al (2006) Analysis of gene expression and chemoresistance of CD133 + cancer stem cells in glioblastoma. Mol Cancer 5:67
15. Bao S, Wu Q, McLendon RE et al (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756–760
16. Nakai E, Park K, Yawata T et al (2009) Enhanced MDR1 expression and chemoresistance of cancer stem cells derived from glioblastoma. Cancer Invest 27:901–908
17. Dean M, Fojo T, Bates S (2005) Tumour stem cells and drug resistance. Nat Rev Cancer 5:275–284
18. Bleau AM, Huse JT, Holland EC (2009) The ABCG2 resistance network of glioblastoma. Cell Cycle 8:2936–2944
19. Wu A, Wiesner S, Xiao J et al (2007) Expression of MHC I and NK ligands on human CD133 + glioma cells: possible targets of immunotherapy. J Neurooncol 83:121–131
20. Wei J, Barr J, Kong LY et al (2010) Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway. Mol Cancer Ther 9:67–78
21. Wei J, Wu A, Kong LY et al (2012) Hypoxia potentiates glioma-mediated immunosuppression. PLoS ONE 6:e16195
22. Scherer HJ (1938) Structural development in gliomas. Am J Cancer 34:333–351
23. Zagzag D, Esencay M, Mendez O et al (2008) Hypoxia- and vascular endothelial growth factor-induced stromal cell-derived factor-1alpha/CXCR4 expression in glioblastomas: one plausible explanation of Scherer’s structures. Am J Pathol 173:545–560
24. Kenig S, Alonso MB, Mueller MM, Lah TT (2010) Glioblastoma and endothelial cells cross-talk, mediated by SDF-1, enhances tumour invasion and endothelial proliferation by increasing expression of cathepsins B, S, and MMP-9. Cancer Lett 289:53–61
25. • Wang R, Chadalavada K, Wilshire J, et al. (2010) Glioblastoma stem-like cells give rise to tumour endothelium. Nature 468:829–833.
26. • Ricci-Vitiani L, Pallini R, Biffoni M, et al. (2010) Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468:824–828.
27. Soda Y, Marumoto T, Friedmann-Morvinski D et al (2011) Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc Natl Acad Sci USA 108:4274–4280
28. Wurmser AE, Nakashima K, Summers RG et al (2004) Cell fusion-independent differentiation of neural stem cells to the endothelial lineage. Nature 430:350–356
29. Goldman SA, Chen Z (2011) Perivascular instruction of cell genesis and fate in the adult brain. Nat Neurosci 14:1382–1389
30. Singh S, Dirks PB (2007) Brain tumor stem cells: identification and concepts. Neurosurg Clin N Am 18:31–38 viii
31. Kappadakunnel M, Eskin A, Dong J et al (2010) Stem cell associated gene expression in glioblastoma multiforme: relationship to survival and the subventricular zone. J Neurooncol 96:359–367
32. Yan X, Ma L, Yi D et al (2011) A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations. Proc Natl Acad Sci USA 108:1591–1596
33. Bao S, Wu Q, Sathornsumetee S et al (2006) Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 66:7843–7848
34. Ikushima H, Miyazono K (2010) TGFbeta signalling: a complex web in cancer progression. Nat Rev Cancer 10:415–424
35. Li Q, Ford MC, Lavik EB, Madri JA (2006) Modeling the neurovascular niche: VEGF- and BDNF-mediated cross-talk between neural stem cells and endothelial cells: an in vitro study. J Neurosci Res 84:1656–1668
36. Pumiglia K, Temple S (2006) PEDF: bridging neurovascular interactions in the stem cell niche. Nat Neurosci 9:299–300
37. Straussman R, Morikawa T, Shee K et al (2012) Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature 487:500–504
38. • Gupta PB, Fillmore CM, Jiang G, et al. (2011) Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 146:633–644.
39. Armulik A, Genove G, Betsholtz C (2011) Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 21:193–215
40. Charles NA, Holland EC, Gilbertson R, Glass R, Kettenmann H (2011) The brain tumor microenvironment. Glia 59:1169–1180
41. Raza A, Franklin MJ, Dudek AZ (2010) Pericytes and vessel maturation during tumor angiogenesis and metastasis. Am J Hematol 85:593–598
42. Nisancioglu MH, Betsholtz C, Genove G (2010) The absence of pericytes does not increase the sensitivity of tumor vasculature to vascular endothelial growth factor-A blockade. Cancer Res 70:5109–5115
43. Campbell RA, Overmyer KA, Selzman CH, Sheridan BC, Wolberg AS (2009) Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability. Blood 114:4886–4896
44. Wilhelmsson U, Faiz M, de Pablo Y et al (2012) Astrocytes negatively regulate neurogenesis through the Jagged1-mediated notch pathway. Stem Cells 30:2320–2329
45. Lee J, Borboa AK, Chun HB, Baird A, Eliceiri BP (2010) Conditional deletion of the focal adhesion kinase FAK alters remodeling of the blood-brain barrier in glioma. Cancer Res 70:10131–10140
46. Yi L, Xiao H, Xu M et al (2011) Glioma-initiating cells: a predominant role in microglia/macrophages tropism to glioma. J Neuroimmunol 232:75–82
47. Wu A, Wei J, Kong LY et al (2010) Glioma cancer stem cells induce immunosuppressive macrophages/microglia. Neuro Oncol 12:1113–1125
48. Ye XZ, Xu SL, Xin YH et al (2012) Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-beta1 signaling pathway. J Immunol 189:444–453
49. Watters JJ, Schartner JM, Badie B (2005) Microglia function in brain tumors. J Neurosci Res 81:447–455
50. Lathia JD, Patton B, Eckley DM et al (2007) Patterns of laminins and integrins in the embryonic ventricular zone of the CNS. J Comp Neurol 505:630–643
51. Kawataki T, Yamane T, Naganuma H et al (2007) Laminin isoforms and their integrin receptors in glioma cell migration and invasiveness: Evidence for a role of alpha5-laminin(s) and alpha3beta1 integrin. Exp Cell Res 313:3819–3831
52. Ljubimova JY, Fugita M, Khazenzon NM et al (2004) Association between laminin-8 and glial tumor grade, recurrence, and patient survival. Cancer 101:604–612
53. Huang P, Rani MR, Ahluwalia MS et al (2012) Endothelial expression of TNF receptor-1 generates a proapoptotic signal inhibited by integrin alpha6beta1 in glioblastoma. Cancer Res 72:1428–1437
54. Kazanis I, Ffrench-Constant C (2012) The number of stem cells in the subependymal zone of the adult rodent brain is correlated with the number of ependymal cells and not with the volume of the niche. Stem Cells Dev 21:1090–1096
55. Gajera CR, Emich H, Lioubinski O et al (2010) LRP2 in ependymal cells regulates BMP signaling in the adult neurogenic niche. J Cell Sci 123:1922–1930
56. Lee C, Hu J, Ralls S et al (2012) The molecular profiles of neural stem cell niche in the adult subventricular zone. PLoS ONE 7:e50501
57. Gilmore AP, Romer LH (1996) Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation. Mol Biol Cell 7:1209–1224
58. Cary LA, Han DC, Polte TR, Hanks SK, Guan J-L (1998) Identification of p130CAS as a mediator of focal adhesion kinase-promoted cell migration. J Cell Biol 140:211–221
59. Stupack DG, Puente XS, Boutsaboualoy S, Storgard CM, Cheresh DA (2001) Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J Cell Biol 155:459–470
60. Hu P, Luo BH (2013) Integrin bi-directional signaling across the plasma membrane. J Cell Physiol 228:306–312
61. Fortunel NO, Otu HH, Ng HH et al (2003) Comment on “ ‘Stemness’: transcriptional profiling of embryonic and adult stem cells” and “a stem cell molecular signature”. Science 302:393 author reply
62. Ivanova NB, Dimos JT, Schaniel C, Hackney JA, Moore KA, Lemischka IR (2002) A stem cell molecular signature. Science 298:601–604
63. Ramalho-Santos M, Yoon S, Matsuzaki Y, Mulligan RC, Melton DA (2002) “Stemness”: transcriptional profiling of embryonic and adult stem cells. Science 298:597–600
64. Lathia JD, Gallagher J, Heddleston JM et al (2010) Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell 6:421–432
65. Kazanis I, Lathia JD, Vadakkan TJ et al (2010) Quiescence and activation of stem and precursor cell populations in the subependymal zone of the mammalian brain are associated with distinct cellular and extracellular matrix signals. J Neurosci 30:9771–9781
66. Fortin S, Le Mercier M, Camby I et al (2010) Galectin-1 is implicated in the protein kinase C epsilon/vimentin-controlled trafficking of integrin-beta1 in glioblastoma cells. Brain Pathol 20:39–49
67. Sakaguchi M, Shingo T, Shimazaki T et al (2006) A carbohydrate-binding protein, Galectin-1, promotes proliferation of adult neural stem cells. Proc Natl Acad Sci USA 103:7112–7117
68. Imaizumi Y, Sakaguchi M, Morishita T et al (2011) Galectin-1 is expressed in early-type neural progenitor cells and down-regulates neurogenesis in the adult hippocampus. Mol Brain 4:7
69. Toussaint LG 3rd, Nilson AE, Goble JM et al (2012) Galectin-1, a gene preferentially expressed at the tumor margin, promotes glioblastoma cell invasion. Mol Cancer 11:32
70. Miura K, Uniyal S, Leabu M et al (2005) Chemokine receptor CXCR4-beta1 integrin axis mediates tumorigenesis of osteosarcoma HOS cells. Biochem Cell Biol 83:36–48
71. Fodde R, Brabletz T (2007) Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol 19:150–158
72. Bolós V, Blanco M, Medina V, Aparicio G, Díaz-Prado S, Grande E (2009) Notch signalling in cancer stem cells. Clin Transl Oncol 11:11–19
73. Bello L, Francolini M, Marthyn P et al (2001) Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery. Neurosurgery 49:380–389 discussion 90
74. Tchaicha JH, Reyes SB, Shin J, Hossain MG, Lang FF, McCarty JH (2011) Glioblastoma angiogenesis and tumor cell invasiveness are differentially regulated by beta8 integrin. Cancer Res 71:6371–6381
75. de Groot JF, Fuller G, Kumar AJ et al (2010) Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice. Neuro Oncol 12:233–242
76. Keunen O, Johansson M, Oudin A et al (2011) Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. Proc Natl Acad Sci USA 108:3749–3754
77. Paez-Ribes M, Allen E, Hudock J et al (2009) Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15:220–231
78. Wick W, Platten M, Weller M (2001) Glioma cell invasion: regulation of metalloproteinase activity by TGF-β. J Neurooncol 53:177–185
79. Sun YX, Fang M, Wang J, Cooper CR, Pienta KJ, Taichman RS (2007) Expression and activation of alpha v beta 3 integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells. Prostate 67:61–73
80. Engl T, Relja B, Marian D et al (2006) CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins. Neoplasia 8:290–301
81. Karpowicz P, Willaime-Morawek S, Balenci L, DeVeale B, Inoue T, van der Kooy D (2009) E-Cadherin regulates neural stem cell self-renewal. J Neurosci 29:3885–3896
82. Hulsken J, Birchmeier W, Behrens J (1994) E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. J Cell Biol 127:2061–2069
83. Lewis JE, Jensen PJ, Johnson KR, Wheelock MJ (1994) E-cadherin mediates adherens junction organization through protein kinase C. J Cell Sci 107(Pt 12):3615–3621
84. Broman MT, Kouklis P, Gao X et al (2006) Cdc42 regulates adherens junction stability and endothelial permeability by inducing alpha-catenin interaction with the vascular endothelial cadherin complex. Circ Res 98:73–80
85. Rasin MR, Gazula VR, Breunig JJ et al (2007) Numb and Numbl are required for maintenance of cadherin-based adhesion and polarity of neural progenitors. Nat Neurosci 10:819–827
86. Rousso DL, Pearson CA, Gaber ZB et al (2012) Foxp-mediated suppression of N-cadherin regulates neuroepithelial character and progenitor maintenance in the CNS. Neuron 74:314–330
87. Lu KV, Chang JP, Parachoniak CA et al (2012) VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex. Cancer Cell 22:21–35
88. Kaur H, Phillips-Mason PJ, Burden-Gulley SM et al (2012) Cadherin-11, a marker of the mesenchymal phenotype, regulates glioblastoma cell migration and survival in vivo. Mol Cancer Res 10:293–304
89. Lewis-Tuffin LJ, Rodriguez F, Giannini C et al (2010) Misregulated E-cadherin expression associated with an aggressive brain tumor phenotype. PLoS ONE 5:e13665
90. Vesuna F, van Diest P, Chen JH, Raman V (2008) Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochem Biophys Res Commun 367:235–241
91. Batlle E, Sancho E, Franci C et al (2000) The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2:84–89
92. Ju D, Sun D, Xiu L, Meng X, Zhang C, Wei P (2011) Interleukin-8 is associated with adhesion, migration and invasion in human gastric cancer SCG-7901 cells. Med Oncol 29:91–99
93. Fernando RI, Castillo MD, Litzinger M, Hamilton DH, Palena C (2011) IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells. Cancer Res 71:5296–5306
94. Samaras V, Piperi C, Levidou G et al (2009) Analysis of interleukin (IL)-8 expression in human astrocytomas: associations with IL-6, cyclooxygenase-2, vascular endothelial growth factor, and microvessel morphometry. Hum Immunol 70:391–397
95. Charalambous C, Pen LB, Su YS, Milan J, Chen TC, Hofman FM (2005) Interleukin-8 differentially regulates migration of tumor-associated and normal human brain endothelial cells. Cancer Res 65:10347–10354
96. Velpula KK, Rehman AA, Chelluboina B et al (2012) Glioma stem cell invasion through regulation of the interconnected ERK, integrin alpha6 and N-cadherin signaling pathway. Cell Signal 24:2076–2084
97. Liu D, Martin V, Fueyo J et al (2010) Tie2/TEK modulates the interaction of glioma and brain tumor stem cells with endothelial cells and promotes an invasive phenotype. Oncotarget 1:700–709
98. • Bergers G, Hanahan D (2008) Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 8:592–603.
99. Casanovas O, Hicklin DJ, Bergers G, Hanahan D (2005) Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell 8:299–309
100. Batchelor TT, Sorensen AG, di Tomaso E et al (2007) AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 11:83–95
101. Du R, Lu KV, Petritsch C et al (2008) HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 13:206–220
102. Jin DK, Shido K, Kopp HG et al (2006) Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4 + hemangiocytes. Nat Med 12:557–567
103. Shaked Y, Tang T, Woloszynek J et al (2009) Contribution of granulocyte colony-stimulating factor to the acute mobilization of endothelial precursor cells by vascular disrupting agents. Cancer Res 69:7524–7528
104. Dong J, Zhao Y, Huang Q et al (2011) Glioma stem/progenitor cells contribute to neovascularization via transdifferentiation. Stem Cell Rev 7:141–152
105. Scully S, Francescone R, Faibish M et al (2012) Transdifferentiation of glioblastoma stem-like cells into mural cells drives vasculogenic mimicry in glioblastomas. J Neurosci 32:12950–12960
106. • Chen R, Nishimura MC, Bumbaca SM, et al. (2010) A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell 17:362–375.
107. Goodman SL, Picard M (2012) Integrins as therapeutic targets. Trends Pharmacol Sci 33:405–412
108. Blaschuk OW, Devemy E (2009) Cadherins as novel targets for anti-cancer therapy. Eur J Pharmacol 625:195–198